Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

EGX:AXPH Income Statement

Financials in millions EGP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	3,024	2,751	1,768	1,484	1,100	1,104
Other Revenue	-3.68	-	-	-	0	-
Revenue	3,020	2,751	1,768	1,484	1,100	1,104
Revenue Growth (YoY)	29.25%	55.56%	19.12%	34.94%	-0.38%	7.75%
Cost of Revenue	2,253	2,092	1,373	1,223	876.78	841.45
Gross Profit	767.03	658.95	395.18	260.89	223.24	262.8
Selling, General & Admin	100.07	102.21	89.77	83.52	75.65	93.71
Other Operating Expenses	41.53	52.04	37.92	22.44	13.05	14.98
Operating Expenses	141.6	154.25	127.69	105.96	88.7	108.69
Operating Income	625.43	504.7	267.49	154.92	134.54	154.11
Interest & Investment Income	15.69	19.56	13.52	5.52	5.55	2.82
Currency Exchange Gain (Loss)	-3.37	-3.01	8.03	11.57	4.4	-0.24
Other Non Operating Income (Expenses)	-	-	0	0	-	0
EBT Excluding Unusual Items	637.75	521.25	289.04	172.02	144.49	156.69
Gain (Loss) on Sale of Assets	-	-	0.56	1.03	-	0.4
Other Unusual Items	-16.84	-12.34	-7.57	-8.1	-0.99	-5.5
Pretax Income	620.9	508.9	282.03	164.95	143.5	151.59
Income Tax Expense	126.86	117.74	65.35	38.52	26.08	34.59
Net Income	494.04	391.17	216.68	126.43	117.42	117
Net Income to Common	494.04	391.17	216.68	126.43	117.42	117
Net Income Growth	61.46%	80.53%	71.39%	7.67%	0.36%	-31.20%
Shares Outstanding (Basic)	5	5	5	5	5	5
Shares Outstanding (Diluted)	5	5	5	5	5	5
Shares Change (YoY)	-	-	-	-	-	-15.35%
EPS (Basic)	98.81	78.23	43.34	25.29	23.48	23.40
EPS (Diluted)	98.81	78.23	43.34	25.29	23.48	23.40
EPS Growth	61.46%	80.53%	71.39%	7.67%	0.36%	-18.73%
Free Cash Flow	292.1	306.27	127.41	7.09	160.9	-20.57
Free Cash Flow Per Share	58.42	61.25	25.48	1.42	32.18	-4.11
Dividend Per Share	62.950	62.950	30.000	13.000	-	10.000
Dividend Growth	109.83%	109.83%	130.77%	-	-	-35.48%
Gross Margin	25.40%	23.96%	22.35%	17.58%	20.29%	23.80%
Operating Margin	20.71%	18.35%	15.13%	10.44%	12.23%	13.96%
Profit Margin	16.36%	14.22%	12.26%	8.52%	10.67%	10.60%
Free Cash Flow Margin	9.67%	11.13%	7.21%	0.48%	14.63%	-1.86%
EBITDA	671.75	547.92	305.05	182.92	157.73	177.74
EBITDA Margin	22.24%	19.92%	17.25%	12.32%	14.34%	16.10%
D&A For EBITDA	46.32	43.22	37.56	28	23.18	23.63
EBIT	625.43	504.7	267.49	154.92	134.54	154.11
EBIT Margin	20.71%	18.35%	15.13%	10.44%	12.23%	13.96%
Effective Tax Rate	20.43%	23.14%	23.17%	23.35%	18.17%	22.82%
Revenue as Reported	3,031	2,762	1,777	1,486	1,101	1,111

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.